Paradise can be defined as a place full of beauty, happiness, joy, and enthusiasm. All of this was recently combined in an exciting scientific meeting on cell death held in Guarujá, São Paulo, Brazil, from November 19–24, 2019. The first [1] and second [2] successful Meetings held in Brazil in 2010 and 2014, respectively, opened the doors to a scientific update this year. The third Meeting on cell death “Why So Many Ways to Die? Apoptosis, Necroptosis, Pyroptosis and Beyond” was organized by KRB, AS, and VMD. Over 150 scientists from all continents, including ones from industry, healthcare professionals as well as principal investigators, postdocs, and graduate students from academia shared 5 days of intense scientific discussions and data exchange.

The Meeting happened at a particularly important moment in the field with the recent discoveries of key regulators and effectors of cell death processes and, importantly, the first drug based on cell death research, the BCL-2 inhibitor venetoclax, now being used routinely in the clinic for the treatment of certain hematological cancers. The excellent talks from prominent more experienced and young scientists were instrumental to improve our understanding of the crosstalk among distinct cell death pathways in health and disease. A fantastic and friendly atmosphere was present during the workshops, short talks, and poster sections, allowing new insights and prospects during discussions.

Log in or create a free account to read this content

Gain free access to this article, as well as selected content from this journal and more on nature.com

Access through your institution

or

Sign in or create an account
Continue with Google
Continue with ORCiD